Loading…
← CockpitCompetitor Analysis › MMSI Merit Medical Systems, Inc.Open in the cockpit ↗

Merit Medical Systems, Inc.MMSICompetitor analysis, valuation and peers

United States · USD·Health Care›Medical Specialties

Maker of single-use medical devices for cardiovascular, endoscopy and interventional radiology procedures.

Momentum strong 73
Mkt cap
$5.15B
US dollars, full cap
Free float
97%
of shares outstanding
$/day
$67.8M
20-day average traded
Fwd P/E
19.1×
forward earnings
ROIC−WACC
+0.8 pp
WACC 7.5%
Hurdle
+3 pp
Req g minus delivered
Next earnings
98 days
24 Feb 2027
Close · USD$85.93
1D+1.7%
1W-2.4%
1M-5.8%
3M-4.8%
6M+33.2%
YTD-2.5%
1Y+0.2%
ATR %3.1%
Beta0.57
52w lowhigh9.4% off high

What Merit Medical Systems does

Maker of single-use medical devices for cardiovascular, endoscopy and interventional radiology procedures.

Sells disposable devices through its own sales force to hospitals, so revenue rises and falls with procedure counts. Procedure kits that bundle several of its products are one route to selling more per hospital. Founded in Utah in 1987, it has grown partly by buying small device businesses.

Products and services

  • Cardiovascular intervention devices (catheters, embolization
  • Endoscopy devices
  • Custom procedural kits/trays

Customers

  • Interventional radiologists/cardiologists
  • Hospitals
  • Ambulatory surgery centers

Where it sits in the supply chain

  • Healthcare
  • Medical devices
  • Cardiovascular and interventional…

What could go right

  • Interventional procedure volume growth
  • New product launches in embolization

What could go wrong

  • Pricing pressure from larger competitors
  • Hospital purchasing consolidation (GPOs)

Moat: narrow (scale, switching costs). Broad catalog of single-use interventional devices with established hospital purchasing relationships.

Headquarters: South Jordan, Utah, USA · Founded: 1987 · Employees: 7,500

Named competitors

Merit Medical Systems at a glance

Size Merit Medical Systems (MMSI) is a United States Health Care company (Medical Specialties) with a market value of $5.15B, the 1159th largest of 3,085 United States companies the cockpit tracks. Shares closed at $85.93 on 18 Nov 2026.

Performance Over six months the shares gained 33.2%, against +23.4% for the median peer and -2.2% for the United States market (cap-weighted) — 8th highest of 21 in its peer set.

Growth Revenue grew 9.3% over the last twelve months (peer median +3.5%); the operating margin is 13.6% (peer median 14.6%).

Valuation It trades at 19.1× forward earnings against a peer median of 20.0× (9th cheapest of 20).

Price implies For today's price to make sense, revenue must grow about 13% a year for seven years (Req g). Recent delivered growth is +9%, so the hurdle is +3 pp: the price needs faster growth than the company has been delivering — of companies that just grew 25–50% a year, 93.8% slowed down over the next four years.

Capital Return on invested capital runs 0.8 points above its cost of capital (7.5% WACC).

Credit Merit Medical Systems has 1 bond outstanding ($748M).

Short interest Short interest is 6.7% of the free float (30 Oct 2026).

Next results Next results expected around 24 Feb 2027 (exchange calendar; dates can move).

Relative performance

10012014021 May 202621 Aug 202618 Nov 2026MMSI 135Peer median 126
Six months, rebased to 100: Merit Medical Systems against the median of its 20 peers (local-currency closes).

Merit Medical Systems financials

Reported figures in USD; fiscal year ends 2025-12-31. TTM = trailing twelve months.
TTMFY2025FY2024FY2023FY2022
Revenue$1.61B$1.51B$1.35B$1.25B$1.15B
Revenue growth—+12%+8%+9%—
Gross profit$797M$737M$641M$522M$469M
EBITDA$355M$319M$271M$223M$191M
Net income$160M$128M$120M$94.4M$74.5M
Free cash flow$204M$216M$186M$111M$69.3M
Capital expenditure$73.2M$84.8M$38.0M$36.7M$48.2M
Total debt$822M$822M$795M$891M$269M

Quarterly statements and history in the cockpit →

Merit Medical Systems competitor charts

The default views of Competitor Analysis ▸ Charts, drawn from the same data. Open them in the cockpit to change the axes, pin companies and read every value.

Performance: 6-month against 1-month return

0%+50%+100%-20%0%+20%LIVN300677DIAMMEDHAESHCGRALICUI688617STVN002223TFXLNTHCOHFIECTECCDNA002432NVSTMMSI6-month return →1-month return →
Up and to the right = strong over both horizons. Merit Medical Systems is the large dot.

Fundamentals: revenue growth against valuation

-20%0%+20%+40%20×40×LIVN300677DIAMMEDHAESHCICUI688617STVNTFXLNTHCOHFIECTECCDNAYPSN002432NVSTMMSIRevenue growth (TTM) →Forward P/E →
Further right = faster growth; higher = more expensive. The dashed lines are the peer medians. Merit Medical Systems is the large dot.

Capital: growth delivered against growth the price implies

0%+20%+40%0%20%40%LIVN300677DIAHAEICUI688617002223TFXLNTHCOHFIECTEC002432MMSIGrowth delivered (Del g) →Growth the price implies (Req g, 7 yrs) →
Above the diagonal = the price needs more growth than the company has been delivering; below = the price already allows for a slowdown. Merit Medical Systems is the large dot.

Merit Medical Systems competitors and peer comparison

Head to head with its named competitors (MMSI vs BSX vs MDT vs BDX)
CompanyMarket cap6M returnRevenue growthOp. marginForward P/EReq g
Merit Medical Systems MMSI$5.15B+33%+9%14%19.1×12.6%
Boston Scientific BSX$63.3B-23%+9%21%14.1×5.8%
Medtronic MDT$129B+30%+10%20%16.8×9.1%
Becton Dickinson BDX$58.9B+48%-7%16%16.3×-1.6%

How Merit Medical Systems compares with its peers

Peer set: Industry: the same industry and sector in any market, nearest in size. This is the same default set the interactive Competitor Analysis opens with.

Merit Medical Systems against its 20 peers (data as of 18 Nov 2026)
MeasureMMSIPeer medianRank in peer set
1-month return-5.8%+8.6%4th lowest of 21
6-month return+33.2%+23.4%8th highest of 21
Distance from 52-week high-9.4%-14.6%10th highest of 21
Revenue growth (TTM)+9.3%+3.5%9th highest of 21
Operating margin13.6%14.6%9th lowest of 21
Forward P/E19.1×20.0×9th cheapest of 20
Growth the price implies (Req g, 7 yrs)12.6%10.0%8th most demanding of 17
Growth delivered (Del g)+9.5%+7.8%6th highest of 17
Hurdle (Req g minus delivered)+3.2 pp+1.8 pp7th most demanding of 17
ROIC minus cost of capital+0.8 pp+2.5 pp9th lowest of 21
EV / EBITDA15.4×13.9×7th most expensive of 15
Net debt / EBITDA0.9×1.1×6th least indebted of 16

Peer table

Peer set: Industry: the same industry and sector in any market, nearest in size
CompanyMarketMarket cap6M returnRevenue growthOp. marginForward P/EReq gDelivered g
Merit Medical Systems MMSIUnited States$5.15B+33%+9%14%19.1×12.6%+9.5%
LivaNova LIVNUnited States$5.21B+28%+12%15%20.9×14.2%+8.2%
Intco Medical Technology 300677.SZChina$4.82B-2%+33%20%18.5×-3.5%-6.4%
DiaSorin DIA.MIItaly$4.81B+24%-3%24%20.5×4.1%+6.3%
MiniMed MMEDUnited States$4.78B+46%+14%14%26.3×n/an/a
Haemonetics HAEUnited States$5.59B+106%+4%19%20.7×10.9%+8.9%
Sotera Health SHCUnited States$4.65B+5%+7%37%15.7×14.4%+7.3%
GRAIL GRALUnited States$4.59B+67%+17%-332%n/an/an/a
ICU Medical ICUIUnited States$4.46B+38%-6%8%19.4×18.9%+11.9%
APT Medical 688617.SSChina$6.06B+23%+28%37%38.6×9.0%+40.1%
Stevanato STVNUnited States$4.19B-13%+12%18%22.5×13.1%+12.1%
Jiangsu Yuyue Medical Equipment & Supply 002223.SZChina$4.18B-3%-1%13%20.0×4.9%+3.4%
Teleflex TFXUnited States$6.58B+23%-29%12%16.7×16.5%-4.7%
Lantheus LNTHUnited States$6.67B+6%+2%19%15.5×0.4%+35.3%
Cochlear COH.AXAustralia$6.72B+58%-1%13%29.1×23.9%+9.3%
Fielmann FIE.DEGermany$3.92B-3%+3%14%17.1×-5.5%+11.3%
ConvaTec CTEC.LUnited Kingdom$6.78B+37%+2%16%17.7×17.2%+4.6%
CareDx CDNAUnited States$3.91B+252%+39%1%50.6×n/an/a
Ypsomed YPSN.SWSwitzerland$6.83B+27%-13%30%31.7×n/an/a
Andon Health 002432.SZChina$3.86B-24%-30%-26%16.1×-6.6%-7.4%
Envista NVSTUnited States$3.81B0%+10%12%14.7×4.8%+7.1%

Merit Medical Systems bonds and credit

Merit Medical Systems has 1 bond outstanding with $748M face value.

Every bond, yield and spread in the cockpit →

Questions

Who are Merit Medical Systems's main competitors?
Named competitors: Boston Scientific (BSX), Medtronic (MDT), Becton Dickinson (BDX). The cockpit's measured peer set (industry) also includes LivaNova (LIVN), Intco Medical Technology (300677.SZ), DiaSorin (DIA.MI), MiniMed (MMED), Haemonetics (HAE), Sotera Health (SHC).
Is Merit Medical Systems expensive compared with its peers?
On forward p/e it trades at 19.1× against a peer median of 20.0×, 9th cheapest of 20 in its peer set. For today's price to make sense, revenue must grow about 13% a year for seven years (Req g). Recent delivered growth is +9%, so the hurdle is +3 pp: the price needs faster growth than the company has been delivering — of companies that just grew 25–50% a year, 93.8% slowed down over the next four years.
How has Merit Medical Systems stock performed?
Over six months to 18 Nov 2026 the shares returned +33.2% against +23.4% for the median peer; over one year +0.2%.

How these numbers are made. Returns are close-to-close in local currency. Revenue growth and margins are trailing twelve months. Req g is the revenue growth that today's enterprise value requires for seven years at the company's own cost of capital; Delivered g is what it actually grew; the gap is the hurdle (honest precision about ±8 points, so read the ranking more than the decimal). No fair values, price targets or analyst ratings are shown, by design. Method and validation.